Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India-here's what ...

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance.

The cost of Ozempic can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Ozempic. Ozempic belongs to a ...

As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the ...

The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...